Abstract
Timegadine (SR 1368,N-cyclohexyl-N″-4-(2-methylquinolyl)-N′-2-thiazolylguanidine) dose-dependently inhibited carrageenan-, nystatin-, and concanavalin A-induced edema. Detailed studies in adjuvant arthritic rats showed: (a) long dosing regime with timegadine inhibited primary and secondary lesions, leukocytosis and hyperfibrinogemia, (b) timegadine was significantly active in reducing the severity of the already established disease, (c) a short course of dosing with timegadine at the time of adjuvant injection permanently prevented the development of secondary lesions. The tuberculin hypersensitivity reaction was enhanced by timegadine in both adjuvant arthritic and normal rats. Experimental allergic encephalomyelitis in rats and guinea pigs was not affected. It is concluded that timegadine has a profile of activity which differs from that of known anti-inflammatory drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. Kishore, S.S. Parmar, S. Kumar andJ.P. Barthwal,Anti-inflammatory and Antiproteolytic Properties of Substituted Guanidines, Pharmacology15, 92–103 (1977).
H.J. Petersen, C. Kaergaard Nielsen andE. Arrigoni-Martelli,Synthesis and Hypotensive Activity of N-Alkyl-N″-Cyano-N′-Pyridylguanidines, J. Med. Chem.21, 773–781 (1978).
S. Rachlin, E. Bramm, I. Ahnfelt-Rønne andE. Arrigoni-Martelli,Basic Anti-inflammatory compound, N, N′, N″-Trisubstituted Guanidines, J. Med. Chem.23, 13–20 (1980).
I. Ahnfelt-Rønne andE. Arrigoni-Martelli,A New Anti-inflammatory Compound, Timegadine (SR 1368, N-Cyclohexyl-N″-4-(2-Methylquinolyl)-N′-2-Thiazolylguanidine), Which Inhibits Both Prostaglandin and 12-HETE Formation, Biochem. Pharmac.29, 3265–3269 (1980).
C.A. Winter, E.A. Risley andG.W. Nuss,Carrageenan-Induced Edema in the Hind Paw of the Rat as an Assay for Anti-inflammatory Drugs, Proc. Soc. exp. Biol. Med.111, 544–547 (1962).
A.J. Lewis, J. Cottney andD.J. Nelson,Mechanism of phytohaemoagglutinin P-, Concanavalin A-, and Kaolin-Induced Edemas in the Rat, Eur. J. Pharmac.40, 1–8 (1976).
E. Arrigoni-Martelli, P. Schiatti andD. Selva,The Influence of Anti-inflammatory and Immunosuppressant Drugs on Nystatin-Induced Edema, Pharmacology5, 215–224 (1971).
E. Bramm, L. Binderup andE. Arrigoni-Martelli,Delayed Hypersensitivity to Tuberculin in Rats: Effects of Antirheumatic Drugs, Acta pharmac. tox.44, 75–80 (1979).
S. Levine andR. Sowinski,Suppression of the Hyperacute Form of Experimental Allergic Encephalomyelitis by Drugs, Archs int. Pharmacodyn Thér.230, 309–318 (1977).
R.D. Sofia, W. Diamantis, R. Gordon, M. Kletzkin, F.M. Berger, J. Edelson, H. Singer andJ.F. Douglas,Pharmacology of a New Non-Steroidal Anti-inflammatory Agent 7-Chloro-3,3α-Dihydro-2-Methyl-2H,9H-Isoxazolo-(3,2-6)(1,3) Benzoxazin-9-One (W-2395), Eur. J. Pharmac.26, 51–62 (1974).
K.F. Swingle, T.J. Grant andD.C. Kvam,Quantal Responses in the Randall-Selitto Assay, Proc. Soc. exp. Biol. Med.137, 536–538 (1972).
M. Di Rosa,Biological Properties of Carrageenan, J. Pharm. Pharmac.24, 89–102 (1972).
D.C. Dumonde andR.N. Maini,The Clinical Significance of Mediators of Cellular Immunity, Clin. Allergy1, 123–131 (1972).
M. Andreis, P. Stastny andM. Ziff,Experimental Arthritis Produced by Injection of Mediators of Delayed Hypersensitivity, Arthritis Rheum.17, 537–540 (1974).
E. Arrigoni-Martelli andA. Restelli,Release of Lysosomal Enzymes in Experimental Inflammations: Effects of Anti-inflammatory Drugs, Eur. J. Pharmac.19, 191–198 (1972).
C.G. Van Arman,Pathway to Adjuvant Arthritis, Fedn Proc.35, 2442–2446 (1976).
R.J. Perper, B. Alvarez, C. Colombo andH. Schroder,The Use of a Standard Adjuvant Assay to Differentiate Between Anti-inflammatory and Immunosuppressive agents, Proc. Soc. exp. Biol. Med.137, 506–512 (1971).
Y.H. Chang,Mechanisms Underlying the Suppression of Adjuvant Induced Arthritis by 6-Mercaptopurine, Arthritis Rheum.20, 1135–1141 (1977).
D.T. Walz, M.J. Di Martino, B. Sutton andA. Misher,SKF 36914: an Agent for Oral Chrysotherapy, J. Pharmac. exp. Thér.181, 212–219 (1972).
J.L. Kalliomaki H.A. Saarinaa andP. Toivanen,Inhibition by 6-Mercaptopurine of Polyarthritis Induced by Freund's Adjuvant, Ann. Rheum. Dis.23, 78–86 (1964).
R.J. Perper, A.L. Oronsky andV. Biancuzzi,Antibody to Mycobacterial Antigen in Adjuvant Arthritis. I. Relationship to Disease and Delayed Hypersensitivity, Arthritis Rheum.15, 283–292 (1972).
E. Arrigoni-Martelli andE. Bramm,Development of Models for Penicillamine-Like Drugs, Rheum. Rehabil.15, 207–210 (1976).
J.A.M. Kerckhaert, G.I. van der Berg andJ.M.N. Willers,Influence of Cyclophosphamide in the Delayed Hypersensitivity of the Mouse, Ann. Immun.125c, 415–426 (1974).
A. Schwartz, P.W. Askenase andR.K. Gershon,Regulation of Delayed Type Hypersensitivity Reactions by Cyclophosphamide Sensitive T-Cells, J. Immun.121, 1573–1577 (1978).
E.M. Glenn, B.J. Bowman, N.A. Rohloff andS.J. Seely,A Major Contributory Cause of Arthritis in Adjuvant Inoculated Rats: Granulocytes, Agents and Actions7, 265–282 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bramm, E., Binderup, L. & Arrigoni-Martelli, E. An unusual profile of activity of a new basic anti-inflammatory drug, timegadine. Agents and Actions 11, 402–409 (1981). https://doi.org/10.1007/BF01982478
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01982478